DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20212672

Comparative study of efficacy of nifedipine, nitroglycerin dermal patches and isoxsuprine as tocolytic agents in suppression of preterm labour 1-year study at navodaya medical college hospital and research centre Raichur

Rita D., V. Haripriya

Abstract


Background: Tocolytic agents are used to reduce preterm deliveries. Very few studies documenting the comparison of tocolytic agents viz. nifedipine, nitroglycerin dermal patches and isoxsuprine. Other drugs are not used due to their adverse effects. Objective was to study and compare the safety efficacy of nifedipine, nitroglycerin dermal patches and isoxsuprine as tocolytic agents in suppression of preterm labour 1 year study.

Methods: This was a prospective case control study was conducted for a period of 1 year. Total 90 cases selected to study were randomly distribute in to three treatment groups viz. A, B, and C nifedipine, nitroglycerin and isoxsuprine respectively. Subjects in all three groups were evaluated for maternal pulse rate, palpitation uterine contractions and fetal heart rate in order to assess efficacy of each drug under investigation.

Results: There was no statistically significant difference in age of woman’s in three different groups. Among (100%) subjects, majority of the cases i.e. (27.8%) primi gravida followed by multi (72.2%). Side effects of nifedipine was less when compared to nitroglycerine dermal patch and isoxsuprine i/v/o of headache (8.9%), nausea (1.1%), vomiting (1.1%), tachycardia (3.3%), palpitation (3.3%), hypotension (1.1%). side effects were statistically significant different between the treatment groups. There was no statistically significant difference with respect to APGAR score at 1 minute and 5 minutes.

Conclusions: Oral nifedipine was found to be superior and efficacious as tocolytic agent as compared to transdermal nitroglycerin and intravenous isoxsuprine.


Keywords


APGAR score, Isoxsuprine, Nifedipine, Nitroglycerin, Preterm labour

Full Text:

PDF

References


Hubinont C, Debieve F. Prevention of preterm labour: 2011 update on tocolysis. J Pregnancy. 2011;2011:941057.

Banerjee BD, Mustafa MD, Sharma T, Tyagi V, Ahmed RS, Tripathi AK, et al. Assessment of toxicogenomic risk factors in etiology of preterm delivery. Reprod Syst Sex Disord. 2014;3(2):1-0.

Rekha S, Pooja G, Patel ML, Shipra C, Reshu A. Clinical evaluation of transdermal nitroglycerine in preterm labor in tertiary care teaching hospital in North India. Int J Sci Res Pub. 2012;2(3):7.

Kaur M, Goel B, Singh J. Comparative study of Nitroglycerine dermal patch versus nifedipine in the management of preterm labour. Int J Reprod Contracept Obstet Gynaecol. 2018;7(10):4244-8.

Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol. 2002;45(1):99- 113.

Duckitt K, Thornton S. Nitric oxide donors for the treatment of preterm labour. Cochrane Database Syst Rev. 2002;3(3):CD002860.

Amorim MM, Lippo LA, Costa AA, Coutinho IC, Souza AS. Transdermal Nitroglycerine versus oral nifedipine administration for tocolysis: a randomized clinical trial. Revista Brasil Ginecol Obstet. 2009;31(11):552-8.

Rowlands S, Trudinger B, Visva-Lingam S. Treatment of preterm cervical dilatation with glyceryl trinitrate a nitric oxide donor. Aust N Z J Obstet Gynaecol. 1996;36(4):377-810.

Leszczynska-Gorzelak B, Laskowska M, Marciniak B, Oleszczuk J. Nitric oxide for treatment of threatened preterm labor. Int J Gynaecol Obstet. 2001;73(3):201-6.

Black RS, Lees C, Thompson C, Pickles A, Campbell S. Maternal and fetal cardio vascular effects of transdermal glyceril trinitrate and intravenous ritodrine. Obstet Gynecol. 1999;94(4):572-6.

Sharma N, Rani S, Huria A, Chawla D. Oral nifedipine versus nitroglycerine patch for tocolysis in preterm labour. Int J Reprod Contracept Obstet Gyenecol. 2019;8(1):174-8.

Kashanian M, Zamen Z, Sheikhansari N. Comparison between nitroglycerine dermal patch and nifedipine for treatment of preterm labor: a randomized clinical trial. J Perinatol. 2014;34(9):683-7.